Journal article

Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: Current practice

Nathan Lawrentschuk, Ian D Davis, Damien M Bolton, Andrew M Scott

INTERNATIONAL JOURNAL OF UROLOGY | WILEY | Published : 2007

Abstract

Nuclear medicine techniques continue to be important non-invasive imaging tools assisting the diagnosis, monitoring and--in some cases--treatment of prostate cancer. Bone scintigraphy was the premier modality to have an extensive role in the staging of prostate cancer and has remained an integral tool for over three decades in the assessment of newly diagnosed disease or in follow-up staging. Therapeutic treatment and palliation of disseminated disease, particularly in the skeleton, has also been successful with several radioisotopes including strontium-89 chloride. Despite advances in nuclear medicine techniques and molecular imaging technology such as positron emission tomography and radio..

View full abstract